Combined radiation-protective and radiation-sensitizing agents. IV: Measurement of intracellular protector concentrations.
Radiosensitization of hypoxic V79 Chinese hamster cells by 0.5 mM misonidazole at approximately 0-4 degrees C is substantially enhanced by pretreating the cells overnight with 0.1 mM buthionine sulfoximine, which lowers the cellular glutathione content to 5% of control values (from 4 mM to approximately 0.2 mM). The enhanced sensitization is reversed by concentrations of exogenous cysteine that are much lower (0.02 mM) than the original glutathione content. Reduced Co-enzyme A affords reversal of the enhancing effect at concentrations of about 1 mM. Sodium ascorbate gives no protection at all even at concentrations of 2 mM. The intracellular concentration of the reducing agents was measured using a spin-through oil technique. There was no diffusion of Co-A (MW greater than 750) or ascorbate (excluded by charge) into the cells. In contrast, cysteine was rapidly concentrated by factors of 4-10, even at the low temperatures used. Extracellular ascorbate's inability to radioprotect argues against electron transfer across the cell membrane as a mechanism for radioprotection. This mechanism could have explained the ability of exogenous thiols to radioprotect in former studies using glutathione, and in the present studies using Co-A. The potential of cysteine to be concentrated by cells poses a problem in the interpretation of "exogenous protection" by non-diffusing thiols, since trace contamination by cysteine could lead to the actual protection observed. Cysteine could also be formed by exchange reactions of exogenous thiols with the disulfide of cysteine, present in all media formulations.
Koch
C J
CJ
University of Pennsylvania, Philadelphia 19104.
Stobbe
C C
CC
Hettiaratchi
P
P
D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000378:metabolism; D019328:Buthionine Sulfoximine; D002460:Cell Line; D003065:Coenzyme A / Q000008:administration & dosage / Q000378:metabolism; D003545:Cysteine / Q000008:administration & dosage / Q000378:metabolism; D005978:Glutathione / Q000502:physiology; D008717:Methionine Sulfoximine / Q000008:administration & dosage / Q000031:analogs & derivatives; D008920:Misonidazole / Q000008:administration & dosage; D011837:Radiation-Protective Agents / Q000008:administration & dosage* / Q000378:metabolism; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage*
D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D008920:Misonidazole; D005978:Glutathione; D003545:Cysteine; D001205:Ascorbic Acid; D003065:Coenzyme A